Literature DB >> 20419816

Human metapneumovirus in hospitalized children in Amman, Jordan.

Syed Asad Ali1, John V Williams, Qingxia Chen, Sameer Faouri, Sameer Faori, Assem Shehabi, Eshan Al Jundi, Najwa Khuri-Bulos, Natasha Halasa.   

Abstract

Human metapneumovirus (HMPV) has recently been identified as an important cause of acute respiratory infections (ARI) in children worldwide. However, there is little systematic data on its frequency and importance as a cause of ARI in the Middle East. We conducted a viral surveillance study in children <5 years of age admitted with respiratory symptoms and/or fever at two major tertiary care hospitals in Amman, Jordan from 1/18-3/29/07. Nose and throat swabs were collected and tested for HMPV and other respiratory viruses by real-time RT-PCR. A total of 743 subjects were enrolled. Forty-four (6%) subjects were positive for HMPV, 467 (64%) were positive for RSV and 13 (1.3%) had co-infection with both HMPV and RSV. The frequency of HMPV in January, February, and March was 4.1%, 3.0%, and 11.9% respectively. Clinical features associated with HMPV infection were similar to those of other respiratory viruses, except children with HMPV were more likely to present with fever than children not infected with HMPV. Children with HMPV and RSV co-infection were administered supplemental oxygen and were admitted to the ICU more frequently than children infected with HMPV alone or RSV alone, though these differences did not reach statistical significance. We conclude that HMPV is an important cause of acute respiratory infections in children in Amman, Jordan. Longer surveillance studies are needed to better understand the seasonal epidemiology of HMPV and to assess if co-infection with HMPV and RSV leads to more severe illness. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20419816      PMCID: PMC3347978          DOI: 10.1002/jmv.21768

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  29 in total

1.  Human metapneumovirus in the community.

Authors:  Ab Osterhaus; Ron Fouchier
Journal:  Lancet       Date:  2003-03-15       Impact factor: 79.321

2.  Real-time reverse transcriptase PCR assay for detection of human metapneumoviruses from all known genetic lineages.

Authors:  Jeroen Maertzdorf; Chiaoyin K Wang; Jennifer B Brown; Joseph D Quinto; Marla Chu; Miranda de Graaf; Bernadette G van den Hoogen; Richard Spaete; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

3.  Real-time PCR to improve the diagnosis of respiratory syncytial virus infection.

Authors:  R Mentel; U Wegner; R Bruns; L Gürtler
Journal:  J Med Microbiol       Date:  2003-10       Impact factor: 2.472

Review 4.  Clinical impact and diagnosis of human metapneumovirus infection.

Authors:  Bernadette G van den Hoogen; D M E Osterhaus; Ron A M Fouchier
Journal:  Pediatr Infect Dis J       Date:  2004-01       Impact factor: 2.129

5.  Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children.

Authors:  John V Williams; Paul A Harris; Sharon J Tollefson; Lisa L Halburnt-Rush; Joyce M Pingsterhaus; Kathryn M Edwards; Peter F Wright; James E Crowe
Journal:  N Engl J Med       Date:  2004-01-29       Impact factor: 91.245

6.  Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients.

Authors:  Bernadette G van den Hoogen; Gerard J J van Doornum; John C Fockens; Jan J Cornelissen; Walter E P Beyer; Ronald de Groot; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  J Infect Dis       Date:  2003-10-27       Impact factor: 5.226

7.  Metapneumovirus and acute wheezing in children.

Authors:  Tuomas Jartti; Bernadette van den Hoogen; Roberto P Garofalo; Albert D M E Osterhaus; Olli Ruuskanen
Journal:  Lancet       Date:  2002-11-02       Impact factor: 79.321

8.  A newly discovered human pneumovirus isolated from young children with respiratory tract disease.

Authors:  B G van den Hoogen; J C de Jong; J Groen; T Kuiken; R de Groot; R A Fouchier; A D Osterhaus
Journal:  Nat Med       Date:  2001-06       Impact factor: 53.440

9.  Human metapneumovirus infections in hospitalized children.

Authors:  Guy Boivin; Gaston De Serres; Stéphanie Côté; Rodica Gilca; Yacine Abed; Louis Rochette; Michel G Bergeron; Pierre Déry
Journal:  Emerg Infect Dis       Date:  2003-06       Impact factor: 6.883

10.  Children with respiratory disease associated with metapneumovirus in Hong Kong.

Authors:  J S Malik Peiris; Wing-Hong Tang; Kwok-Hung Chan; Pek-Lan Khong; Yi Guan; Yu-Lung Lau; Susan S Chiu
Journal:  Emerg Infect Dis       Date:  2003-06       Impact factor: 6.883

View more
  25 in total

1.  Human Metapneumovirus Infection in Jordanian Children: Epidemiology and Risk Factors for Severe Disease.

Authors:  Jennifer E Schuster; Najwa Khuri-Bulos; Samir Faouri; Asem Shehabi; Monika Johnson; Li Wang; Christopher Fonnesbeck; John V Williams; Natasha Halasa
Journal:  Pediatr Infect Dis J       Date:  2015-12       Impact factor: 2.129

Review 2.  Human Metapneumovirus: lessons learned over the first decade.

Authors:  Verena Schildgen; Bernadette van den Hoogen; Ron Fouchier; Ralph A Tripp; Rene Alvarez; Catherine Manoha; John Williams; Oliver Schildgen
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

3.  Large-scale seroprevalence analysis of human metapneumovirus and human respiratory syncytial virus infections in Beijing, China.

Authors:  Guilan Lu; Richard Gonzalez; Li Guo; Chao Wu; Jiang Wu; Guy Vernet; Gláucia Paranhos-Baccalà; Jianwei Wang; Tao Hung
Journal:  Virol J       Date:  2011-02-10       Impact factor: 4.099

4.  Comparative epidemiology of human metapneumovirus- and respiratory syncytial virus-associated hospitalizations in Guatemala.

Authors:  John P McCracken; Wences Arvelo; José Ortíz; Lissette Reyes; Jennifer Gray; Alejandra Estevez; Oscar Castañeda; Gayle Langley; Kim A Lindblade
Journal:  Influenza Other Respir Viruses       Date:  2014-04-25       Impact factor: 4.380

5.  Middle East respiratory syndrome coronavirus not detected in children hospitalized with acute respiratory illness in Amman, Jordan, March 2010 to September 2012.

Authors:  N Khuri-Bulos; D C Payne; X Lu; D Erdman; L Wang; S Faouri; A Shehabi; M Johnson; M M Becker; M R Denison; J V Williams; N B Halasa
Journal:  Clin Microbiol Infect       Date:  2013-12-09       Impact factor: 8.067

6.  Viral etiology, seasonality and severity of hospitalized patients with severe acute respiratory infections in the Eastern Mediterranean Region, 2007-2014.

Authors:  Katherine C Horton; Erica L Dueger; Amr Kandeel; Mohamed Abdallat; Amani El-Kholy; Salah Al-Awaidy; Abdul Hakim Kohlani; Hanaa Amer; Abel Latif El-Khal; Mayar Said; Brent House; Guillermo Pimentel; Maha Talaat
Journal:  PLoS One       Date:  2017-07-13       Impact factor: 3.240

Review 7.  Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance.

Authors:  Qiu Sue Huang; Nikki Turner; Michael G Baker; Deborah A Williamson; Conroy Wong; Richard Webby; Marc-Alain Widdowson
Journal:  Influenza Other Respir Viruses       Date:  2015-07       Impact factor: 4.380

8.  Influenza A viruses dual and multiple infections with other respiratory viruses and risk of hospitalisation and mortality.

Authors:  Edward Goka; Pamela Vallely; Kenneth Mutton; Paul Klapper
Journal:  Influenza Other Respir Viruses       Date:  2012-10-19       Impact factor: 4.380

9.  Vitamin D deficiency among newborns in Amman, Jordan.

Authors:  Najwa Khuri-Bulos; Ryan D Lang; Meridith Blevins; Katherine Kudyba; Lindsey Lawrence; Mario Davidson; Samir Faouri; Natasha B Halasa
Journal:  Glob J Health Sci       Date:  2013-11-06

10.  Detection of Human Metapneumovirus and Respiratory Syncytial Virus by Real-Time Polymerase Chain Reaction Among Hospitalized Young Children in Iran.

Authors:  Masoud Parsania; Behzad Poopak; Mohammad Hassan Pouriayevali; Sama Haghighi; Aref Amirkhani; Alireza Nateghian
Journal:  Jundishapur J Microbiol       Date:  2016-03-15       Impact factor: 0.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.